NASDAQ:LPCN

Lipocine Stock Insider Trading

etoro logo Buy LPCN
*Your capital is at risk
$2.19
-0.0600 (-2.67%)
At Close: Jun 03, 2026

Lipocine Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.31M and sold 0 LPCN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 3.31M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 07, 2026
Buy
Common stock
P-Purchase
Higuchi John W.
Director
Director 40 000
Value: $81.2K
Apr 06, 2026
Buy
Common stock
P-Purchase
Higuchi John W.
Director
Director 123 000
Value: $252.2K
Apr 06, 2026
Buy
Common stock
P-Purchase
Patel Mahesh V.
Chief Executive Officer
CEO / President 25 000
Value: $50.8K
Apr 02, 2026
Buy
Common stock
P-Purchase
Patel Mahesh V.
Chief Executive Officer
CEO / President 25 000
Value: $50.5K
Jan 02, 2026
Buy
Stock Option (Right to Buy)
A-Award
Patel Mahesh V.
Chief Executive Officer
CEO / President 25 000
Value: $200.0K
Dec 18, 2025
Buy
Stock Option (Right to Buy)
A-Award
Patel Mahesh V.
Chief Executive Officer
CEO / President 8 629
Value: $36.2K
Dec 18, 2025
Buy
Stock Option (Right to Buy)
A-Award
Fogarty Krista
Principal Accounting Officer
Officer 20 786
Value: $87.3K
Jun 04, 2025
Buy
Common Stock (Right to Buy)
A-Award
Ono Richard Dana
Director
Director 1 764
Value: $6K
Jun 04, 2025
Buy
Stock Option (Right to Buy)
A-Award
Jene Jill M.
Director
Director 1 764
Value: $6K
Jun 04, 2025
Buy
Stock Option (Right to Buy)
A-Award
Papapetropoulos Spyros
Director
Director 1 764
Value: $6K
Jun 04, 2025
Buy
Common Stock (Right to Buy)
A-Award
Fink Jeffrey Arvin
Director
Director 1 764
Value: $6K
Jun 04, 2025
Buy
Common Stock (Right to Buy)
A-Award
Higuchi John W.
Director
Director 1 764
Value: $6K
Jun 04, 2025
Buy
Common Stock (Right to Buy)
A-Award
Higuchi John W.
Director
Director 1 764
Value: $6K
Jun 04, 2025
Buy
Common Stock (Right to Buy)
A-Award
Fink Jeffrey Arvin
Director
Director 1 764
Value: $6K
Jun 04, 2025
Buy
Stock Option (Right to Buy)
A-Award
Papapetropoulos Spyros
Director
Director 1 764
Value: $6K
Jun 04, 2025
Buy
Stock Option (Right to Buy)
A-Award
Jene Jill M.
Director
Director 1 764
Value: $6K
Jun 04, 2025
Buy
Common Stock (Right to Buy)
A-Award
Ono Richard Dana
Director
Director 1 764
Value: $6K
Jan 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Patel Mahesh V.
Chief Executive Officer
CEO / President 16 371
Value: $79.6K
Jan 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Patel Mahesh V.
Chief Executive Officer
CEO / President 16 371
Value: $79.6K
Dec 23, 2024
Buy
Stock Option (Right to Buy)
A-Award
Patel Mahesh V.
Chief Executive Officer
CEO / President 10 320
Value: $49.5K
Dec 23, 2024
Buy
Stock Option (Right to Buy)
A-Award
Patel Mahesh V.
Chief Executive Officer
CEO / President 10 320
Value: $49.5K
Dec 23, 2024
Buy
Stock Option (Right to Buy)
A-Award
Patel Mahesh V.
Chief Executive Officer
CEO / President 26 691
Value: $128.1K
Dec 23, 2024
Buy
Stock Option (Right to Buy)
A-Award
Fogarty Krista
Principal Accounting Officer
Officer 5 943
Value: $28.5K
Dec 23, 2024
Buy
Stock Option (Right to Buy)
A-Award
Fogarty Krista
Principal Accounting Officer
Officer 5 943
Value: $28.5K
Dec 23, 2024
Buy
Stock Option (Right to Buy)
A-Award
Patel Mahesh V.
Chief Executive Officer
CEO / President 26 691
Value: $128.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT LIPOCINE INC.
Lipocine
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioident...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE